Emerging Directions: Cognitive and Sexual Wellness Peptides New categories of peptides are reshaping how longevity medicine addresses areas that conventional therapies often overlook
It has been increasingly shown that after recovery from COVID-19, survivors may exhibit persistently elevated blood pressure (BP) and sustained tachycardia, which can manifest in various forms such as sinus tachycardia at rest, inappropriate sinus tachycardia (IST) or postural orthostatic tachycardia syndrome (32, 33, 46)
R., Bauer, P
Frohman, MD Landmark Publications Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these medications following rigorous clinical trials demonstrating their efficacy in glycaemic control, with some agents (liraglutide, dulaglutide, and semaglutide) also showing cardiovascular benefits in specific populations
Currently, the underlying mechanism of these effects is still not fully illustrated and a better understanding of them may help identify promising therapeutic targets of AD, hypertension, and NASH
:max_bytes(150000):strip_icc():focal(1035x393:1037x395)/Equinox-261223-01-90398a1f386047f4a2bf76661eb49426.jpg)
